Filing Details

 

	UNITED STATES
	SECURITIES AND EXCHANGE COMMISSION
	Washington, D.C. 20549
	SCHEDULE 13D

 

Under the Securities Exchange Act of 1934
(Amendment No. 1)*

 

(Name of Issuer)

 

(Title of Class of Securities)

 

(CUSIP Number)

 

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

 

(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this statement on Schedule 13D (this Schedule 13D), and is filing this Schedule 13D because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box. o

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See Rule 13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (the Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

SCHEDULE 13D

 

 

(1) Based on the 186,170,213 common shares representing limited partnership interests (Shares) outstanding according to the Form 10-Q filed by Antero Midstream GP LP (the Issuer) with the U.S. Securities and Exchange Commission (the SEC) on June 2, 2017.

 

2

 

 

(1) Based on the 186,170,213 Shares outstanding according to the Form 10-Q filed by the Issuer with the SEC on June 2, 2017.

 

3

 

 

(1) Based on the 186,170,213 Shares outstanding according to the Form 10-Q filed by the Issuer with the SEC on June 2, 2017.

 

4

 

 

(1) Based on the 186,170,213 Shares outstanding according to the Form 10-Q filed by the Issuer with the SEC on June 2, 2017.

 

5

 

 

(1) Based on the 186,170,213 Shares outstanding according to the Form 10-Q filed by the Issuer with the SEC on June 2, 2017.

 

6

 

 

(1) Based on the 186,170,213 Shares outstanding according to the Form 10-Q filed by the Issuer with the SEC on June 2, 2017.

 

7

 

 

(1) Based on the 186,170,213 Shares outstanding according to the Form 10-Q filed by the Issuer with the SEC on June 2, 2017.

 

8

 

 

(1) Based on the 186,170,213 Shares outstanding according to the Form 10-Q filed by the Issuer with the SEC on June 2, 2017.

 

9

 

 

(1) Based on the 186,170,213 Shares outstanding according to the Form 10-Q filed by the Issuer with the SEC on June 2, 2017.

 

10

 

 

(1) Based on the 186,170,213 Shares outstanding according to the Form 10-Q filed by the Issuer with the SEC on June 2, 2017.

 

11

 

 

(1) Based on the 186,170,213 Shares outstanding according to the Form 10-Q filed by the Issuer with the SEC on June 2, 2017.

 

12

 

 

INTRODUCTION

 

This amends and supplements the Schedule 13D filed on May 22, 2017 (the Original Schedule 13D, and together with this amendment, the Schedule 13D) with the Securities and Exchange Commission by Warburg Pincus Private Equity VIII, L.P., a Delaware limited partnership (WP VIII, and together with its two affiliated partnerships, Warburg Pincus Netherlands Private Equity VIII C.V. I, a limited partnership formed under the laws of the Netherlands (WP VIII CV I), and WP-WPVIII Investors, L.P., a Delaware limited partnership (WP-WPVIII Investors), collectively, the WP VIII Funds); Warburg Pincus Private Equity X O&G, L.P., a Delaware limited partnership (WP X O&G, and together with its affiliated partnership, Warburg Pincus X Partners, L.P., a Delaware limited partnership, the WP X O&G Funds); Warburg Pincus X, L.P., a Delaware limited partnership (WP X GP), which is the general partner of each of the WP X O&G Funds; Warburg Pincus X GP L.P., a Delaware limited partnership (WP X GP LP), which is the general partner of WP X GP; WPP GP LLC, a Delaware limited liability company (WPP GP), which is the general partner of WP X GP LP and WP-WPVIII Investors GP L.P., a Delaware limited partnership (WP-WPVIII GP), which is the general partner of WP-WPVIII Investors; Warburg Pincus Partners, L.P., a Delaware limited partnership (WP Partners), which is (i) the managing member of WPP GP, and (ii) the general partner of WP VIII and WP VIII CV I; Warburg Pincus Partners GP LLC, a Delaware limited liability company (WP Partners GP), which is the general partner of WP Partners; Warburg Pincus & Co., a New York general partnership (WP), which is the managing member of WP Partners GP;  Warburg Pincus LLC, a New York limited liability company (WP LLC), which is the manager of each of the WP VIII Funds and the WP X O&G Funds; and Charles R. Kaye and Joseph P. Landy, who are the Managing General Partners of WP and the Managing Members and Co-Chief Executive Officers of WP LLC and may be deemed to control the Warburg Pincus Entities (as defined below).  Each of the WP VIII Funds, the WP X O&G Funds, WP X GP, WP X GP LP, WPP GP, WP Partners, WP Partners GP, WP and WP LLC are collectively referred to herein as the Warburg Pincus Entities and together with Charles R. Kaye and Joseph P. Landy, the Reporting Persons. Capitalized terms used but not defined herein shall have the meaning set forth in the Original Schedule 13D.

 

The purpose of this amendment is to report a greater than 1% change in ownership of the common shares representing limited partnership interests (the Shares) issued by Antero Midstream GP LP (the Issuer) held by the Reporting Persons.

 

Item 3. Source or Amount of Funds or Other Consideration.

 

The Shares of the Issuer were distributed pro rata to each of the members of Antero Resources Investment LLC, a Delaware limited liability company (ARI), by ARI for no consideration.

 

Item 5. Interest in Securities of the Issuer.

 

The Reporting Persons listed below have the following beneficial ownership of Shares (percentages are based on 186,170,213 Shares outstanding according to the Form 10-Q filed by the Issuer with the U.S. Securities and Exchange Commission on June 2, 2017):

 

(i)                                     WP VIII has shared dispositive and voting power over 18,568,833 Shares of the Issuer, representing 9.97% of the outstanding Shares of the Issuer.

 

(ii)                                  WP X O&G has shared dispositive and voting power over 34,834,296 Shares of the Issuer, representing 18.71% of the outstanding Shares of the Issuer.

 

(iii)                               WP X GP has shared dispositive and voting power over 35,948,706 Shares of the Issuer, representing 19.31% of the outstanding Shares of the Issuer.

 

13

 

 

(iv)                              WP X GP LP has shared dispositive and voting power over 35,948,706 Shares of the Issuer, representing 19.31% of the outstanding Shares of the Issuer.

 

(v)                                 WPP GP has shared dispositive and voting power over 36,002,529 Shares of the Issuer, representing 19.34% of the outstanding Shares of the Issuer.

 

(vi)                              WP Partners has shared dispositive and voting power over 55,109,589 Shares of the Issuer, representing 29.60% of the outstanding Shares of the Issuer.

 

(vii)                           WP Partners GP has shared dispositive and voting power over 55,109,589 Shares of the Issuer, representing 29.60% of the outstanding Shares of the Issuer.

 

(viii)                        WP has shared dispositive and voting power over 55,109,589 Shares of the Issuer, representing 29.60% of the outstanding Shares of the Issuer.

 

(ix)                              WP LLC has shared dispositive and voting power over 55,109,589 Shares of the Issuer, representing 29.60% of the outstanding Shares of the Issuer.

 

(x)                                 Charles R. Kaye has shared dispositive and voting power over 55,109,589 Shares of the Issuer, representing 29.60% of the outstanding Shares of the Issuer.

 

(xi)                              Joseph P. Landy has shared dispositive and voting power over 55,109,589 Shares of the Issuer, representing 29.60% of the outstanding Shares of the Issuer.

 

Each of the Reporting Persons listed in this Item 5(i) through 5(xi) could be deemed to have beneficial ownership of all of the Shares reported in this Schedule 13D; nevertheless, each of the Reporting Persons disclaims beneficial ownership of shares in excess of that reported in this Item 5.  Each of Messrs. Kaye and Landy disclaims beneficial ownership of the Shares owned by the other Reporting Persons.

 

Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person.

 

Except as reported in the Original Schedule 13D, during the last sixty (60) days there were no transactions in the Shares effected by the Reporting Persons.

 

Except as set forth in this Item 5 and for persons referred to in Item 2 of the Original Schedule 13D, no person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares that may be deemed to be beneficially owned by the Reporting Persons.

 

14

 

 

SIGNATURES

 

After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this Schedule 13D is true, complete and correct.

 

Dated:  June 13, 2017

 

 

WARBURG PINCUS PRIVATE EQUITY VIII, L.P.

 

By:              Warburg Pincus Partners, L.P., its general partner
By:              Warburg Pincus Partners GP LLC, its general partner
By:              Warburg Pincus & Co., its managing member

 

 

By:	/s/ Robert B. Knauss		Date:	June 13, 2017
	Name: Robert B. Knauss
	Title: Partner

 

 

WARBURG PINCUS PRIVATE EQUITY X O&G, L.P.

 

By:              Warburg Pincus X, L.P., its general partner
By:              Warburg Pincus X GP L.P., its general partner
By:              WPP GP LLC, its general partner
By:              Warburg Pincus Partners, L.P., its managing member
By:              Warburg Pincus Partners GP LLC, its general partner
By:              Warburg Pincus & Co., its managing member

 

By:	/s/ Robert B. Knauss		Date:	June 13, 2017
	Name: Robert B. Knauss
	Title: Partner

 

 

WARBURG PINCUS X, L.P.

 

By:              Warburg Pincus X GP L.P., its general partner
By:              WPP GP LLC, its general partner
By:              Warburg Pincus Partners, L.P., its managing member
By:              Warburg Pincus Partners GP LLC, its general partner
By:              Warburg Pincus & Co., its managing member

 

By:	/s/ Robert B. Knauss		Date:	June 13, 2017
	Name: Robert B. Knauss
	Title: Partner

 

 

WARBURG PINCUS X GP L.P.

 

By:              WPP GP LLC, its general partner
By:              Warburg Pincus Partners, L.P., its managing member
By:              Warburg Pincus Partners GP LLC, its general partner
By:              Warburg Pincus & Co., its managing member

 

By:	/s/ Robert B. Knauss		Date:	June 13, 2017
	Name: Robert B. Knauss
	Title: Partner

 

15

 

 

WPP GP LLC

 

By:              Warburg Pincus Partners, L.P., its managing member
By:              Warburg Pincus Partners GP LLC, its general partner
By:              Warburg Pincus & Co., its managing member

 

By:	/s/ Robert B. Knauss		Date:	June 13, 2017
	Name: Robert B. Knauss
	Title: Partner

 

 

WARBURG PINCUS PARTNERS, L.P.

 

By:              Warburg Pincus Partners GP LLC, its general partner
By:              Warburg Pincus & Co., its managing member

 

 

By:	/s/ Robert B. Knauss		Date:	June 13, 2017
	Name: Robert B. Knauss
	Title: Partner

 

 

WARBURG PINCUS PARTNERS GP LLC

 

By:              Warburg Pincus & Co., its managing member

 

By:	/s/ Robert B. Knauss		Date:	June 13, 2017
	Name: Robert B. Knauss
	Title: Partner

 

 

WARBURG PINCUS & CO.

 

 

By:	/s/ Robert B. Knauss		Date:	June 13, 2017
	Name: Robert B. Knauss
	Title: Partner

 

 

WARBURG PINCUS LLC

 

 

By:	/s/ Robert B. Knauss		Date:	June 13, 2017
	Name: Robert B. Knauss
	Title: Managing Director

 

16

 

 

/s/ Charles R. Kaye		Date:	June 13, 2017
Name: Charles R. Kaye
Title: Robert B. Knauss, Attorney-in-Fact*

 

 

/s/ Joseph P. Landy		Date:	June 13, 2017
Name: Joseph P. Landy
Title: Robert B. Knauss, Attorney-in-Fact*

 

*The Power of Attorney given by each of Mr. Kaye and Mr. Landy was previously filed with the SEC on July 12, 2016 as an exhibit to the statement on Schedule 13D filed by Warburg Pincus LLC with respect to Wex Inc. and is hereby incorporated by reference.

 

17